This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Lifshitz Law Firm Announces Investigation Of CapLease, Inc., Lender Processing Services, Inc., Omthera Pharmaceuticals, Inc. And Vitamin Shoppe, Inc.

NEW YORK, May 28, 2013  /PRNewswire/ --

CapLease, Inc.  

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of CapLease, Inc. ("CapLease") (LSE) to American Realty Capital Properties, Inc. in a transaction valued at approximately $2.2 billion or $8.50 per share for each outstanding share of CapLease common stock, and each share of Series A, Series B and Series C preferred stock of CapLease will be converted into the right to receive the sum of $25.00 in cash plus an amount equal to any accrued and unpaid dividends up to but excluding the closing date of the merger.

Lifshitz Law Firm's investigation is focused on whether the proposed deal provides adequate value to the CapLease's shareholders.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Lender Processing Services, Inc.

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Lender Processing Services, Inc. (LPS) to Fidelity National Financial, Inc. in a transaction valued at approximately $2.9 billion or $33.25 per share in cash.

Lifshitz Law Firm's investigation is focused on whether the proposed deal provides adequate value to the Company's shareholders.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Omthera Pharmaceuticals, Inc.

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Omthera Pharmaceuticals, Inc. ("Omthera") (OMTH) to AstraZeneca in a cash transaction valued at approximately $323 million or $12.70 per share.

Lifshitz Law Firm's investigation is focused on whether the proposed transaction provides adequate value to the Omthera's shareholders.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs